EPISODE · Nov 1, 2022 · 11 MIN
Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.
from Answers from the Lab · host Mayo Clinic Laboratories
(00:32) Could you provide a little bit of background about yourself?(01:43) Could you give a brief overview of the new melanoma assay?(04:53) Is the assay able to provide diagnostic, prognostic and classification information, and potential therapeutic implications?(05:12) Could you talk a little more about the MSI assessment in this panel? (05:59) Which patients should have this testing?(07:01) How are these results used in patient care?(08:39) Is there anything else you'd like to add?
What this episode covers
Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' expanded melanoma panel can enhance patient care. The updated assay provides more comprehensive genomic coverage to better classify melanoma tumors and guide treatment decisions.
NOW PLAYING
Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m